I was alarmed to read the recent National Audit Office (NAO) report on prescribing in primary care which points to cheaper drug alternatives to solve the NHS' financial problems.
The report claims that the main 'culprits' seem to be antiplatelets and statins, two crucial drug classes for cardiovascular patients.
Since the NAO hasn't looked at any of the clinical evidence surrounding these treatments and seems quite reluctant to allow GPs the clinical freedom to prescribe what is best for patients, I hope that GPs will resist this interference for as long as possible.
Cardiac patients rely on GPs to deliver the best care based on their individual needs.
Financially driven guidance like this, which seems to be independent of clinical or patient considerations, is irresponsible.
Eve Knight, British Cardiac Patients Association, Bromley, Kent.